LZL50 is an orally effective human caseinolytic protease P (hClpP) activator with an EC50 of 0.29 µM. LZL50 activates hClpP, a serine protease that mediates mitochondrial quality control by degrading damaged or misfolded mitochondrial proteins. LZL50 exhibits antitumor activity in a breast cancer xenograft mouse model. LZL50 can be used in research related to breast cancer[1].
Molecular Weight:
555.61
Formula:
C31H33F4N3O2
Target:
Ser/Thr Protease
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
